Cost-effectiveness of primary HPV genotyping and dual-stain or cytology reflex testing versus cytology-based screening for cervical cancer in Chile
Fig 3
Probabilistic Sensitivity Analysis Results for Cervical Cancer Screening Strategies.
A) Scatter plot of PSA simulations for the hrHPV-CINtec-5 strategy versus PAP-3; B) Scatter plot for the hrHPV-PAP-5 strategy versus PAP-3; C) Cost-effectiveness acceptability curve (CEAC) corresponding to panel (A); D) CEAC corresponding to panel (B). Dashed vertical lines represent the willingness-to-pay threshold set at one GDP per capita (USD$17.093 according to World Bank).